INTERNATIONAL PATENT: GENZYME CORPORATION FILES APPLICATION FOR "AAV-MEDIATED OCULAR GENE THERAPY"

GENEVA, March 25 -- GENZYME CORPORATION (450 Water StreetCambridge, Massachusetts 02141) filed a patent application (PCT/US2025/046226) for "AAV-MEDIATED OCULAR GENE THERAPY" on Sep 12, 2025. With publication no. WO/2026/060286, the details related to the patent application was published on Mar 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JACOBS, Suzanne (c/o Sanofi, Patent Department450 Water StreetCambridge, Massachusetts 02141), O'RIORDAN, Catherine (c/o Sanofi, Patent Department450 Water StreetCambridge, Massachusetts 02141), SULLIVAN, Jennifer (c/o Sanofi, Patent Department450 Wa...